Comparative Effects of Interferon Alpha-2b and Pegylated Interferon Alpha-2b on Menstrual Cycles and Ovarian Hormones in Cynomolgus Monkeys

被引:4
|
作者
Enright, Brian P. [1 ]
Compton, David R. [1 ]
Collins, Nathaniel [1 ]
Davis, Thomas [1 ]
McIntyre, Barry S. [1 ]
机构
[1] Schering Plough Res Inst, Summit, NJ 07901 USA
关键词
interferon; estradiol; progesterone; menstrual cycle; monkey; reproductive toxicity; ALPHA; PROGESTERONE; ANTIBODIES; SECRETION; RECEPTOR; THERAPY; IFN;
D O I
10.1002/bdrb.20179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The covalent modification of interferon (IFN) alpha 2b with monomethyoxy polyethylene glycol (PEG) reduces its clearance rate and increases its half-life. High doses of interferon (IFN) alpha 2b have previously been shown to affect maintenance of pregnancy in rhesus monkeys, Given the role of ovarian hormones in reproductive function and pregnancy, this study was conducted to assess the effects of PEG-IFN alpha 2b or IFN alpha 2b (comparative control) on ovarian hormones and menstrual cyclicity in cynomolgus monkeys. In addition, the potential for reversibility of PEG-IFN alpha 2b or IFN alpha 2b-related observations was assessed. METHODS: Monkeys were administered 3,105 mu g/m(2) human recombinant (hr) IFN alpha 2b or 52, 262, or 4,239 mu g/m(2) PEG-hr-IFN alpha 2b every other day for one menstrual cycle, followed by a post-dose period of up to two menstrual cycles, RESULTS: Monkeys administered 3,105 mu g/m(2) hr-IFN alpha 2b or 52, 262, or 4,239 mu g/m(2) PEG-hr-IFN alpha 2b exhibited transient decreases in food consumption, leukocyte and erythrocyte parameters. Monkeys administered 3,105 mu g/m(2) hr-IFN alpha 2b exhibited lengthened menstrual cycles that were associated with a delay in reaching peak ovarian hormone levels and lower respective peak concentrations. Similarly, monkeys administered 4,239 mu g/m(2) PEG-hr-IFN alpha 2b exhibited lengthened menstrual cycles and a delay in reaching peak ovarian hormone levels and slightly lower respective peak concentrations. Post-dosing menstrual cycle length, estradiol and progesterone profiles exhibited evidence of recovery in both the hr-IFN alpha 2b and the high-dose PEG-hr-IFN alpha 2b groups. CONCLUSIONS: Administration of hr-IFN alpha 2b or PEG-hr-IFN alpha 2b at high doses to cynomolgus monkeys resulted in similar effects on menstrual cycles, estradiol and progesterone profiles, and exhibited evidence of reversibility upon cessation of dosing. These results suggest that the previously observed high-dose IFN alpha-related effects on the maintenance of pregnancy in monkeys are likely the result of altered ovarian function. Birth Defects Res (Part B) 86:29-39, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:29 / 39
页数:11
相关论文
共 50 条
  • [1] Pegylated Interferon Alpha-2b Related Delirium
    Ustun, Cemal
    Ustun, Suzan
    Demir, Caner Feyzi
    KONURALP TIP DERGISI, 2012, 4 (03): : 59 - 61
  • [2] ALPHA-2B INTERFERON AND HYPOTHYROIDISM
    JAVIER, RM
    SIBILIA, J
    KUNTZ, JL
    SCHLIENGER, JL
    ASCH, L
    REVUE DU RHUMATISME, 1992, 59 (7-8): : 501 - 501
  • [3] Identification of the major positional isomer of pegylated interferon alpha-2b
    Wang, YS
    Youngster, S
    Bausch, J
    Zhang, RM
    McNemar, C
    Wyss, DF
    BIOCHEMISTRY, 2000, 39 (35) : 10634 - 10640
  • [4] Structure, biology, and therapeutic implications of pegylated interferon alpha-2b
    Youngster, S
    Wang, YS
    Grace, M
    Bausch, J
    Bordens, R
    Wyss, DF
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (24) : 2139 - 2157
  • [5] Acute dystonia after injection of pegylated interferon alpha-2b
    Quarantini, Lucas C.
    Miranda-Scippa, Angela
    Parana, Raymundo
    Sampaio, Aline Santos
    Bressan, Rodrigo A.
    MOVEMENT DISORDERS, 2007, 22 (05) : 747 - 748
  • [6] INTERFERON ALPHA-2B IN THE TREATMENT OF MYELOFIBROSIS
    FURESI, L
    PASINI, FL
    FORCONI, S
    HAEMATOLOGICA, 1990, 75 (06) : 587 - 589
  • [7] INTRAVENTRICULAR ALPHA-2B INTERFERON FOR SSPE
    MITCHELL, WG
    CRAWFORD, TO
    NEUROLOGY, 1987, 37 (12) : 1884 - 1884
  • [8] Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms
    Teng, Guangshuai
    Zhang, Yuhui
    Du, Chenxiao
    Wang, Yan
    Hu, Naibo
    Han, Yingdi
    Ma, Jinyu
    Gao, Shan
    Xiang, Guangpeng
    Shao, Zonghong
    Bai, Jie
    BLOOD, 2022, 140 : 3959 - 3960
  • [9] Treatment of acute hepatitis C with pegylated interferon alpha-2b and ribavirin
    Capozza, TA
    Brann, OS
    Coyle, WJ
    Schindler, WR
    BeMiller, TA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S188 - S188
  • [10] Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy
    Bettoli, Vincenzo
    Mantovani, Lucia
    Boccia, Sergio
    Virgili, Annarosa
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (03) : 258 - 259